135 related articles for article (PubMed ID: 31115032)
1. The efficacy of simendan in the treatment of acute heart failure and its impact on NT-proBNP.
Li J; Wang XY; Yang ZY; Li Y; Yang F; Yuan P; Yang J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4027-4032. PubMed ID: 31115032
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of levosimendan in elderly patients with severe heart failure].
Wang YB; Yu YH; Gong SJ; Yan J; Wang Y
Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):433-438. PubMed ID: 32486583
[No Abstract] [Full Text] [Related]
3. Short-term efficacy and safety of levosimendan in patients with chronic systolic heart failure.
Cui XR; Yang XH; Li RB; Wang D; Jia M; Bai L; Zhang JD
Cardiovasc J Afr; 2020; 31(4):196-200. PubMed ID: 32555927
[TBL] [Abstract][Full Text] [Related]
4. [Safety and efficacy of the early administration of levosimendan in patients with acute non-ST-segment elevation myocardial infarction and elevated NT-proBNP levels: An Early Management Strategy of Acute Heart Failure (EMS-AHF)].
Xu F; Bian Y; Zhang GQ; Gao LY; Liu YF; Liu TX; Li G; Song RX; Su LJ; Zhou YJ; Cui JY; Yan XL; Guo FM; Zhang HY; Li QH; Zhao M; Ma LK; You BA; Wang G; Kong L; Ma JL; Zhou XF; Chang ZL; Tang ZY; Yu DY; Cheng K; Xue L; Li X; Pang JJ; Wang JL; Zhang HT; Yu XZ; Chen YG
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):374-383. PubMed ID: 37032132
[No Abstract] [Full Text] [Related]
5. Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
Cui D; Liao Y; Li G; Chen Y
Am J Cardiovasc Drugs; 2021 Jan; 21(1):73-81. PubMed ID: 32462455
[TBL] [Abstract][Full Text] [Related]
6. Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure.
Zheng YR; Ye LF; Cen XJ; Lin JY; Fu JW; Wang LH
Int J Cardiol; 2017 Feb; 228():666-671. PubMed ID: 27883979
[TBL] [Abstract][Full Text] [Related]
7. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
8. Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure.
Duan HY; Liu DM; Qian P; Wang SL; Yan LJ; Wu JT; Yang HT; Fan XW; Chu YJ
Genet Mol Res; 2015 Dec; 14(4):15739-48. PubMed ID: 26634541
[TBL] [Abstract][Full Text] [Related]
9. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
[TBL] [Abstract][Full Text] [Related]
10. Analysis of combined detection of N-terminal pro-B-type natriuretic peptide and left ventricular ejection fraction in heart function in patients with acute CO poisoning.
Liu SD; Shen Q; Lv C; Zhang P; Yu H; Yang L; Wu L
Am J Emerg Med; 2014 Oct; 32(10):1212-4. PubMed ID: 25151325
[TBL] [Abstract][Full Text] [Related]
11. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
Comín-Colet J; Manito N; Segovia-Cubero J; Delgado J; García Pinilla JM; Almenar L; Crespo-Leiro MG; Sionis A; Blasco T; Pascual-Figal D; Gonzalez-Vilchez F; Lambert-Rodríguez JL; Grau M; Bruguera J;
Eur J Heart Fail; 2018 Jul; 20(7):1128-1136. PubMed ID: 29405611
[TBL] [Abstract][Full Text] [Related]
13. [Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].
Wang F; Xu ZM; Wang L; Bian WY; Jia X; Duan B; Li W; Li YS
Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):490-4. PubMed ID: 16080835
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
[TBL] [Abstract][Full Text] [Related]
15. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of plasma N-terminal pro-brain natriuretic peptide in diagnosis of diastolic heart dysfunction].
Ma GZ; Yu DQ; Cai ZX; Xu RH; Ni CM
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1631-4. PubMed ID: 20650787
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure.
Gao Y; Xing C; Hao W; Zhao H; Wang L; Luan B; Hou A
Int Heart J; 2020 Jan; 61(1):1-6. PubMed ID: 31875616
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial.
Butler J; Anstrom KJ; Felker GM; Givertz MM; Kalogeropoulos AP; Konstam MA; Mann DL; Margulies KB; McNulty SE; Mentz RJ; Redfield MM; Tang WHW; Whellan DJ; Shah M; Desvigne-Nickens P; Hernandez AF; Braunwald E;
JAMA Cardiol; 2017 Sep; 2(9):950-958. PubMed ID: 28700781
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]